NCT05809440
- Conditions
- Transplant;Failure,Kidney
- Locations
-
- University of Malaya Medical Center Kuala Lumpur, Malaysia
Clinical trial condition
Transplant;Failure,Kidney
Explore clinical trials studying Transplant;Failure,Kidney. Study availability and eligibility vary by location and protocol.
19 public trials
4 recruiting studies
Transplant;Failure,Kidney trial results
NCT05790746
- Conditions
- Transplant;Failure,Kidney
- Locations
-
- Ondokuz Mayıs University, Department of Urology Samsun, Turkey (Türkiye)
Completed
Clinical Pharmacy Guided Patient Counselling and Adherence Support on Renal Transplant Recipients
NCT04715412
- Conditions
- Transplant;Failure,Kidney
- Locations
-
- Transplantation Clinic Nasser Institute Cairo, Egypt
NCT03765203
- Conditions
- Transplant;Failure,Kidney
- Locations
-
- QURE Healthcare San Francisco, California, United States
NCT03723668
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +6 more
- Locations
-
- Kidney Transplantation Care at Veteran's Affairs Medical Center Philadelphia, Pennsylvania, United States
- Paris Transplant Group Paris, France
Active, Not Recruiting
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
NCT03737604
- Conditions
- Neurologic Manifestations, Pain, Pain, Postoperative, +5 more
- Locations
-
- University of California Davis Sacramento, California, United States
Active, Not Recruiting
Dietary Intervention to Improve Kidney Transplant Outcomes
NCT05449496
- Conditions
- Body Weight, Cardiovascular Diseases, Diabetes, +23 more
- Locations
-
- UC Davis Sacramento, California, United States
Active, Not Recruiting
Continuous Spinal Anesthesia in Renal Transplantation
NCT03436368
- Conditions
- Anesthesia, Chronic Disease, Disease Attributes, +13 more
- Locations
-
- Kasr Al-Ainy Hospital, Cairo University Cairo, Egypt
Active, Not Recruiting
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
NCT03380962
- Conditions
- Antibody-mediated Rejection, Behavior, Chronic Disease, +19 more
- Locations
-
- Norko Ammerman Los Angeles, California, United States